Speciality Medicines IPO Details
| IPO Open Date | March 20, 2026 |
| IPO Close Date | March 24, 2026 |
| Face Value | â‚ą10 Per Equity Share |
| IPO Price Band | â‚ą117 to â‚ą124 Per Share |
| Issue Size | Approx â‚ą29.14 Crores |
| Fresh Issue | Approx â‚ą29.14 Crores |
| Issue Type | Book build Issue |
| IPO Listing | BSE SME |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Speciality Medicines IPO Review & Key Points
- Review:
Speciality Medicines IPO Market Lot
The Speciality Medicines IPO minimum market lot is 2,000 shares with â‚ą2,48,000 application amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 2,000 | â‚ą2,48,000 |
| Retail Maximum | 2 | 2,000 | â‚ą2,48,000 |
| S-HNI Minimum | 3 | 3,000 | â‚ą3,72,000 |
| S-HNI Maximum | 8 | 8,000 | â‚ą9,92,000 |
| B-HNI Minimum | 9 | 9,000 | â‚ą11,16,000 |
IPO Reservation
| Investor Category | Share Offered | Shares (%) |
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | – Shares | 2% |
| NII Shares Offered | – Shares | 49% |
| Retail Shares Offered | – Shares | 49% |
Speciality Medicines IPO Anchor Investors
| Anchor Bidding Date | 2026 |
| Anchor Investors List | |
| Shares Offered | [.] Shares |
| Anchor Size | [.] Cr. |
| lock-in period end date 50% shares (30 Days) | 2026 |
| lock-in period end date 50% shares (90 Days) | 2026 |
Speciality Medicines IPO Dates
The Speciality Medicines IPO date is March 20 and the close date is March 24. The Speciality Medicines IPO allotment will be finalized on March 25 and the IPO listing on March 30.
| IPO Open Date: | March 20, 2026 |
| IPO Close Date: | March 24, 2026 |
| Basis of Allotment: | March 25, 2026 |
| Refunds: | March 27, 2026 |
| Credit to Demat Account: | March 27, 2026 |
| IPO Listing Date: | March 30, 2026 |
| IPO Bidding Cut-off Time: | March 24, 2026 – 5 PM |
Promoters and Holding Pattern
The promoters of the company are Parth B Goyani and Goyani Sumit Babubhai.
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 64,35,796 | 59.28% |
| Promoter Holding Post Issue | 87,85,796 | 43.44% |
Objects of the Issue & Utilisation of Proceeds
| Purpose | Crores |
| Setting up of the Research and Development (R&D) Centre | â‚ą13.31 |
| Product registration in the international markets | â‚ą2.89 |
| Repayment/ Prepayment, in full or part, of certain borrowings availed by the Company | â‚ą1.75 |
| To Meet Working Capital Requirements | â‚ą12.00 |
| General Corporate Purpose | â‚ą- |
About Speciality Medicines IPO
To be updated soon
Speciality Medicines IPO Company Financial Report
Amount â‚ą in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2024 | â‚ą27.66 | â‚ą23.10 | â‚ą2.93 | â‚ą22.68 |
| 2025 | â‚ą58.54 | â‚ą49.85 | â‚ą8.61 | â‚ą39.98 |
Speciality Medicines IPO Valuation – FY2025
Check Speciality Medicines IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 37.85% |
| ROCE: | 33.39% |
| EBITDA Margin: | 15.60% |
| PAT Margin: | 14.77% |
| Debt to equity ratio: | 0.17 |
| Earning Per Share (EPS): | â‚ą14.10 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 28.42% |
| Net Asset Value (NAV): | â‚ą47.07 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Remus Pharmaceuticals Limited | 65.21 | 12.25 | 15.02% | 434.25 | 620.36 Cr. |
| Trident Lifeline Limited | 10.22 | 27.59 | 18.23% | 56.05 | 86.96 Cr. |
| Mono Pharmacare Limited | 1.75 | 13.87 | 9.90% | 17.66 | 168.34 Cr. |
IPO Lead Managers aka Merchant Bankers
- Unicon Capital Services Pvt. Ltd.Â
Company Address
Speciality Medicines Ltd.
913, One World West, S. No. 396, FP 119,
Village- Vejalpur, Ahmadabad City,
Ahmedabad, Gujarat, India,
Ahmedabad, Gujarat, 380051
Phone: +91 22 4604 5344
Email: investors.grievances@specialitymedicine.com
Website: https://www.specialitymedicine.com/
IPO Registrar
Skyline Financial Services Pvt. Ltd.
Phone: 02228511022
Email: ipo@skylinerta.com
Website: https://www.skylinerta.com/ipo.php
Speciality Medicines IPO FAQs
What is Speciality Medicines IPO?
Speciality Medicines IPO is SME IPO. The company is going to raise â‚ą29.14 Crores via IPO. The issue is priced at â‚ą117 to â‚ą124 per equity share. The IPO is to be listed on BSE.
When Speciality Medicines IPO will open for subscription?
The IPO is to open on March 20, 2026 for QIB, NII, and Retail Investors. The IPO will close on March 24, 2026.
What is Speciality Medicines IPO Investors Portion?
The investors’ portion for QIB is 2%, NII is 49%, and Retail is 49%.
How to Apply the Speciality Medicines IPO?
You can apply for Speciality Medicines IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.
What is Speciality Medicines IPO Issue Size?
Speciality Medicines IPO issue size is â‚ą29.14 crores.
What is Speciality Medicines IPO Price Band?
Speciality Medicines IPO Price Band is â‚ą117 to â‚ą124.
What is Speciality Medicines IPO Lot Size?
The minimum bid is 2,000 Shares with â‚ą2,48,000 amount.
What is the Speciality Medicines IPO Allotment Date?
Speciality Medicines IPO allotment date is March 25, 2026.
What is the Speciality Medicines IPO Listing Date?
Speciality Medicines IPO listing date is March 30, 2026. The IPO is to list on BSE.
Note: The Speciality Medicines IPO price band and date are officially announced. The (Speciality Medicines IPO grey market premium) will be added to the IPO GMP page as it will start).
